O

Oxygenta Pharmaceutical Limited

OXYGENTAPH
Market snapshot · 2026-08-11 15:45 UTC

65.64

+₹10.94 (+20.00%)

MARKET CAP

₹242.76 Cr

STOCK P/E

52W HIGH

₹100.00

52W LOW

₹43.00

BOOK VALUE

₹-11.56

EPS

₹-3.67

ROE

SECTOR

Health Care

DEBT/EQUITY

VOLUME

51,367

P/B RATIO

-5.68x

PEG RATIO

Sector

Health Care

Themes

Pharmaceuticals
₹88.80₹78.27₹67.73₹57.19₹46.66VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/S
Strongly Overvalued

5Y Average

1.30

Current

1.80

Overvalued

1.49

Undervalued

1.10

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹37 CrJun 2026

Latest net profit

₹-2.10 CrJun 2026

Latest EPS

₹-0.57Jun 2026

Net margin

1.5%Jun 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27-60.0%-40.0%-20.0%0.0%20.0%-20 Cr0.00 Cr20 Cr40 Cr60 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q1 '26Q2 '26Q3 '26Q4 '26Q1 '270.00 Cr15 Cr30 Cr45 Cr60 Cr₹-2₹-1₹-1₹-1₹-0
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherOtheradjustmentsNet Profit-13 Cr0.00 Cr13 Cr26 Cr39 Cr

Latest reported period: Jun 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-45 Cr0.00 Cr45 Cr90 Cr135 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales +6.8613.089.1510.5512.6214.0133.2149.4715.1314.3033.9349.6137.00
Expenses +10.5015.0611.6312.1714.4016.1837.5751.1521.9618.8738.0149.4936.45
Operating Profit-3.64-1.98-2.48-1.62-1.78-2.17-4.36-1.68-6.83-4.57-4.080.120.55
OPM %-53.06%-15.14%-27.10%-15.36%-14.10%-15.49%-13.13%-3.40%-45.14%-31.96%-12.02%0.24%1.49%
Other Income +-0.13-0.03-0.020.260.020.750.49-0.220.16-0.06-0.000.170.02
Interest0.290.340.360.590.410.690.392.130.630.951.391.812.46
Depreciation0.500.830.690.640.650.660.71-0.230.850.860.86-0.240.62
Profit before tax-4.56-3.18-3.55-2.59-2.82-2.77-4.97-3.80-8.15-6.44-6.33-1.28-2.51
Tax %-0.00%-0.63%6.48%-409.27%-51.42%2.89%-20.72%-43.42%-25.03%-23.45%-23.38%32.81%-15.94%
Net Profit +-4.56-3.16-3.788.02-1.36-2.85-3.93-2.15-6.11-4.93-4.84-1.70-2.10
EPS in Rs-1.36-0.94-1.132.40-0.38-0.80-1.06-0.58-1.65-1.33-1.31-0.46-0.57
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +57.95%57.95%55.93%56.53%56.53%
DIIs +0.03%0.03%0.03%0.03%0.03%
Public +42.02%42.01%44.05%43.44%43.43%
Others0.01%0.01%
Jun 2026
Promoters +
DIIs +
Public +
Others

Events Timeline

Newspaper Advertisement

Jul 31, 2026PDFCompany Reports Open

Intimation Of Book Closure And Cut-Off Date For The 33Rd Annual General Meeting Of Oxygenta Pharmaceutical Limited.

Jul 30, 2026PDFCompany Reports Open

Reg. 34 (1) Annual Report.

Jul 30, 2026PDFCompany Reports Open

Submission Of Notice Of 33Rd Annual General Meeting For The Finanical Year 2025-26.

Jul 30, 2026PDFCompany Reports Open

Un-Audited Results For The Quarter Ended 30.06.2026.

Jul 27, 2026PDFCompany Reports Open